US Broker Ratings

AbbVie Inc. (ABBV) Stock Analysis: Healthcare Giant’s Strong Revenue Growth and Robust Dividend Attract Investors

AbbVie Inc. (ABBV), a leader in the healthcare sector, continues to capture the attention of individual investors with its potent mix of robust revenue growth and..

Regeneron Pharmaceuticals (REGN) Investor Outlook: A 28% Potential Upside Amidst Market Volatility

Regeneron Pharmaceuticals, Inc. (REGN), a heavyweight in the biotechnology industry, offers investors a compelling opportunity despite recent market fluctuations. With a market capitalization of $59.77 billion,..

Bristol-Myers Squibb Company (BMY) Stock Analysis: 20% Upside Potential Amid Strong Dividend Yield

Investors seeking stability amidst the fluctuating waves of the healthcare sector may find Bristol-Myers Squibb Company (NYSE: BMY) an intriguing option. With a market capitalization of..

Cardinal Health, Inc. (CAH) Investor Outlook: Exploring a 17.61% Potential Upside

Cardinal Health, Inc. (NYSE: CAH), a cornerstone in the healthcare sector’s medical distribution industry, has garnered significant attention from investors due to its robust business model..

Mettler-Toledo International, Inc. (MTD): Investor Outlook on a Precision Instrument Pioneer with 8.46% Upside Potential

Mettler-Toledo International, Inc. (NYSE: MTD) stands as a formidable entity in the diagnostics and research industry, part of the broader healthcare sector. With a market capitalization..

STERIS plc (STE) Stock Analysis: Discovering the 9.35% Potential Upside in Healthcare Innovation

For investors with a keen eye on the healthcare sector, STERIS plc (NYSE: STE) presents a compelling opportunity. Positioned as a leader in infection prevention products..

CVS Health Corporation (CVS) Stock Analysis: Exploring the 8.88% Upside Potential

CVS Health Corporation (NYSE: CVS), a titan in the healthcare sector, is an intriguing prospect for investors seeking stable growth with a healthy dividend yield. With..

Zoetis Inc. (ZTS) Stock Analysis: Exploring a 32% Potential Upside in Animal Health Innovation

Zoetis Inc. (NYSE: ZTS), a leader in the healthcare sector, particularly within the specialty and generic drug manufacturing industry, is drawing significant investor attention. With its..

BioNTech SE (BNTX) Investor Outlook: Analyzing a 38.78% Potential Upside Amid Robust Revenue Growth

BioNTech SE (NASDAQ: BNTX), a leading player in the biotechnology sector, has captivated investor attention with its promising pipeline of immunotherapies aimed at treating cancer and..

Becton, Dickinson and Company (BDX): Investor Outlook with a 12.82% Potential Upside

Becton, Dickinson and Company (NYSE: BDX), a leader in the healthcare sector particularly in medical instruments and supplies, offers a promising investment case for individual investors..

Humana Inc. (HUM) Investor Outlook: Analyzing a 17% Potential Upside in the Healthcare Plans Sector

Humana Inc. (NYSE: HUM) stands as a notable player in the healthcare plans sector, commanding a market capitalization of $30.66 billion. The company provides a comprehensive..

The Cigna Group (CI) Stock Analysis: Exploring a 28.99% Potential Upside for Healthcare Investors

The Cigna Group (NYSE: CI) stands as a formidable player in the healthcare sector, specifically within the healthcare plans industry. With a robust market capitalization of..

Abbott Laboratories (ABT) Stock Analysis: Navigating Growth in the Healthcare Sector with a 6.87% Upside

Abbott Laboratories (NYSE: ABT), a titan in the healthcare sector, continues to solidify its position as a leading player in the medical devices industry. With a..

Intuitive Surgical, Inc. (ISRG) Stock Analysis: Exploring a 31.96% Upside Potential

Intuitive Surgical, Inc. (NASDAQ: ISRG) continues to capture the attention of investors with its innovative solutions in the healthcare sector. With a market capitalization of $158.13..

Vertex Pharmaceuticals (VRTX) Stock Analysis: Evaluating Growth Potential with a 24% Upside

Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) continues to be a compelling prospect for investors seeking growth in the biotechnology sector. With a market capitalization of $98.9 billion,..

Pfizer, Inc. (PFE) Stock Analysis: Navigating a 21.65% Potential Upside with a Robust Dividend Yield

Pfizer, Inc. (PFE), a stalwart in the healthcare sector, continues to command investor attention with its significant market presence and promising financial indicators. With a market..

Sanofi (SNY) Stock Analysis: Unpacking a 35% Upside Potential for Investors

Sanofi (SNY), a behemoth in the healthcare sector, particularly in the drug manufacturing industry, continues to be a cornerstone for investors seeking stable growth and substantial..

Veeva Systems Inc. (VEEV) Stock Analysis: Unveiling a Potential 9.11% Upside for Investors

Investors focusing on the healthcare technology space might want to turn their attention to Veeva Systems Inc. (NYSE: VEEV), a pivotal player in the health information..

Alcon Inc. (ALC) Stock Analysis: Eyeing a 32% Upside with Strong Buy Ratings

Alcon Inc. (NYSE: ALC), a global leader in the eye care sector, emerges as a compelling investment opportunity with a significant upside potential. Headquartered in Geneva,..

Takeda Pharmaceutical Company L (TAK) Stock Analysis: Potential 23.43% Upside Beckons Investors

Takeda Pharmaceutical Company Limited (NYSE: TAK), a stalwart in the healthcare sector, particularly in drug manufacturing, continues to be a focal point for investors who are..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds